Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Spring Gate Capital is a Singapore-based global asset management and hedge fund manager focused on long-term value investing. Its flagship fund, originally the China-focused "Spring Gate Capital China Fund," was relaunched as the "Spring Gate Capital Global Alpha Fund" in 2024 to invest globally with a focus on technology and innovation. The fund has consistently outperformed relevant indices since inception.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spring Gate Capital.